Life Science Connect (“LSC”) is pleased to announce the appointment of Douglas Emslie to its Board of Directors. Mr. Emslie will focus his efforts on further developing LSC’s live event capabilities and offerings. With several decades of experience building influential event portfolios that foster collaboration, partnerships, and industry growth, Mr. Emslie brings substantial expertise to this role. LSC is a portfolio Company of Latticework Capital Management and Edgehill Management.

LSC, headquartered in Pittsburgh, Pennsylvania, is an intelligent, data-driven platform designed for B2B connection, collaboration, and contribution. As a leader in digital media for the life sciences, LSC is committed to enhancing professional connections within the sector to accelerate research, development, manufacturing, and the application of scientific innovations.

Mr. Emslie, a seasoned business leader and investor with extensive experience in the events and exhibitions industry, was most recently CEO of Tarsus Group, having joined the business when it was launched in 1998. He previously held senior positions at Blenheim Group plc and after its takeover, United Business Media plc. Mr. Emslie is a past Chairman and Director of the Association of Event Organizers (AEO), as well as past Chairman of the Events Industry Alliance. He is a board member of US industry advocacy body, the Exhibitions & Conferences Alliance (ECA) and was also the first international board member of the US industry trade body, SISO, where he went on to serve as Chair. Mr. Emslie oversaw the acquisition of Tarsus Group by Informa plc. and now, as head of Cuil Bay Capital, he is rapidly expanding his events investment portfolio with more than 10 assets to date. In his spare time, he runs marathons and ultra-marathons around the world. He is also Chairman of the Trustees of the Green Hub for Teens charity.

Commenting on his appointment, Mr. Emslie stated, “There is tremendous potential to develop a world-class event portfolio within the life sciences sector. Life Science Connect already possesses a robust foundation of content and community; now is the optimal time to facilitate face-to-face engagement to advance collaboration and commercialization.”

Jon Howland, CEO of Life Science Connect, added, “We are delighted to welcome Doug Emslie to our Board. His outstanding track record in founding and growing Tarsus into a global leader in live events equips him with invaluable insight and energy as Life Science Connect continues to expand its connection platforms beyond digital, email, and social channels.”

The appointment of Mr. Emslie reflects the company’s broader strategic investment to enter the live events sector in 2026. LSC is expanding its live events capabilities through both organic growth and M&A, aiming to capitalize on its established expertise and relationships within the life sciences industry.

LSC is actively seeking acquisition and growth opportunities to help expand their suite of capabilities for B2B sales and marketing enablement and to reach new audiences. Please contact Jon Howland (jon.howland@lifescienceleader.com) to connect further regarding a potential acquisition.

About Life Science Connect

Life Science Connect is a network of life science go-to-work solutions dedicated to a better way of connecting professionals across life science communities to advance the pace of research, development, manufacturing, and use of life science innovations. Life Science Connect facilitates mutually beneficial connections between audiences and strategic partners that accelerate the advancement of life-improving, life-extending, and life-saving therapies and devices. LSC serves a loyal, professional readership that demands original, compelling content with professional applications and facilitates engagement across the drug development lifecycle through leading digital publications, events, podcasts, and more. To learn more visit www.lifescienceconnect.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250923771647/en/